Pelican-Cancer-Foundation-logos
Donate Now
Search
Pelican-Cancer-Foundation-logos

Dedicated to helping patients with bowel and liver cancer live well for longer

Donate Now
Search
  • Home
  • About us
    • About us
    • What we do
      • Our achievements
      • The Future
    • Who we are
      • Trustees
      • Our Team
      • Patrons
      • Annual Accounts
    • Partnerships
    • Vacancies
    • News
  • Education
    • Pelican OReCO
      • OReCO On-line Resources
      • OReCO Partners & Sponsors
      • Pelican OReCO Workshops
    • Pelican IMPACT
      • IMPACT – Completion & Evaluation
      • Workshops
      • IMPACT – Online resources
      • IMPACT – Partners and Sponsors
    • SPECC
      • SPECC – Completion & Evaluation
      • Workshops
      • SPECC – Online resources
      • SPECC – Partners and Sponsors
    • LOREC
    • TIPTOP
      • Workshops
      • TIPTOP – Online resources
      • Bob’s story (prostate cancer)
      • Andrew’s story (prostate cancer)
      • Alan’s story (prostate cancer)
      • Raymond’s story (prostate cancer)
    • LARS
    • Sponsors
      • Become a sponsor
    • Request a course or topic
    • Give us feedback
    • Previous courses
  • Films
  • Research
    • MERCURY 3
    • Research strategy
    • Bowel cancer research
      • POLARS
      • MERCURY 2 (Low Rectal Cancer Study)
      • Deferral of surgery study
      • TATME
      • IMPRESS
      • TRIGGER
      • Papers of interest
      • Timing of surgery
      • AMSOEC
      • MINSTREL
      • Completed research
        • Perineal wound healing registry
        • Beyond TME
        • Validation of the LARS score
        • MARVEL: Evaluation of EMVI positive rectal cancer
        • FLEX
        • TME Physical Simulation Model
        • Total Mesorectal Excision (TME)
        • MERCURY research programme
    • Liver cancer research
      • Completed research
        • EORTC studies
      • SERENADE
      • Papers of interest
    • Peritoneal malignancy research
      • Colorectal Peritoneal Malignancy Database
      • Pseudomyxoma Pathology Atlas
    • Previous Research Areas
      • Prostate Cancer Research
        • Prostate cancer
        • Focal therapy and HIFU research
        • MRI research for prostate cancer
        • Prostate cancer colloquiums
        • FORECAST
        • Trachtomap
        • Papers of interest
      • Bladder cancer research
        • Bladder cancer
        • Papers of interest
    • Peer reviewers
    • Clinical trials
    • Information for research applicants
      • Peer Review Panel Terms of Reference
      • Research Review Panel
      • Research Grant Application Guidance Notes
      • Terms and conditions of grants
      • Animals in medical research
      • Research costs
    • Surgical videos
  • For Patients
    • Patient stories
      • Anthony’s story (bowel cancer)
      • Elena’s story (bowel cancer)
      • Terry’s story (liver cancer)
      • Derrick’s story (liver cancer)
      • Alex’s story (colorectal cancer)
      • Cheryll’s story (rectal cancer)
      • Eileen’s story
      • Richard’s story – irrigation
      • Tom’s story – complete response
      • Advanced metastatic bowel cancer
    • What is an MDT?
      • What an MRI reveals
      • Reporting cancer outcomes
    • Bowel cancer
      • Our bowel cancer team
      • About bowel cancer treatment – TME
      • April – Bowel Cancer Awareness Month
      • Low rectal cancer
      • Complete response to chemoradiotherapy in rectal cancer
      • Frequently asked questions about bowel cancer
      • Irrigation for colostomies
      • A patient’s advice
      • Symptom checker
      • Bowel cancer – useful contacts
    • Liver cancer
      • Our liver cancer team
      • About liver cancer treatment
      • Interventional radiology
      • Liver cancer – frequently asked questions
      • Carcinoid and neuroendocrine tumours
      • Liver cancer – want to read more?
    • Pseudomyxoma peritonei
    • Getting a second opinion
    • Clinical trials
      • Current clinical trials
    • Tell us your story
    • Still got questions about cancer?
    • Links
  • Support us
    • Make a donation
      • Make a donation
      • Shares
      • In memory
    • Fundraise for us
      • Our fundraisers
      • Fundraising ideas
      • Fundraising challenges
      • Fundraising resources
    • Leave a Gift in your Will
    • Become a Corporate Partner
    • Trusts, Foundations & Philanthropy
    • Tell us your story
  • Contact us

Pelican OReCO Workshops

Previous Pelican workshops have helped to refine treatment and improve outcomes and the principles and concepts of these workshops have been replicated in part, or in whole, in many parts of the world.

The OReCO national education programme will see 20 one-day workshops delivered from January 2024 to December 2026. The workshops will be funded by charitable resources and there will be no charge for delegate attendance.

 

Year Region Date Location Status
2024 Wessex 24 January Basingstoke Completed
South Wales 11 March Newport Completed
London 1 2 May London Completed
North Wales 19 July Conwy Completed
Scotland 1 11 September Edinburgh Completed
Oxfordshire 7 November Oxford Completed
2025 Trent 30 January Nottingham Completed
Yorkshire 13 March York Completed
London 2 8 May London Completed
Republic of Ireland 2 September Dublin
Northern Ireland 4 September Belfast
Scotland 2 8 October Glasgow
South West 6 November Bristol
2026 West Midlands 21 January Birmingham
North West March Manchester
Northern May Newcastle
East Anglia July Cambridge
London 3 September Central London
Mersey November Liverpool
Wash Up December Basingstoke

Workshop Overview

London Chapter : 8 May 2025 : London

In total, 123 clinicians attended the second OReCO London workshop from 29 hospitals across the London region.

  • Very interesting discussions regarding organ preservation in early rectal cancers and management of complex rectal cancers. LARS topic was excellent.
  • Good update and discussion of new concepts and techniques. Interesting case discussion on complex management issues. Thank you.
  • It validates our practice having a dedicated rectal cancer MDT and dedicated rectal cancer surgeons.
  • It surely will guide me to detect early complications and risks and will help to address/signpost patients to available services.

Yorkshire Chapter: 13 March 2025: York

In total, 94 clinicians attended the OReCO Yorkshire workshop from 16 hospitals across the Yorkshire region.

  • I enjoyed all sessions and gained more knowledge in organ preservation. Acknowledged lack of knowledge and support for patients with LARS.
  • This workshop has given me confidence to lessen the importance of nodal status.
  • I think the surgeons will have a better insight into the challenges of TNT and organ preservation after this. I think we will have better debate about the pros and cons.
  • Will push for key information from Radiology more and ensure a better understanding of patient information.

Trent Chapter: 30 January 2025: Nottingham

In total, 51 clinicians attended the OReCO Trent workshop from 4 hospitals across the Trent region.

  • Interesting changes afoot. It is a great opportunity to see how things have progressed / will progress in the treatment of colorectal cancer.
  • It has given me more confidence in that we all doing our best for better outcomes.
  • Enhancing my knowledge will allow a greater knowledge to pass onto my patients.
  • Useful for understanding patient options and informed consenting. Clear focus on MDT working and teamwork.

Oxford Chapter : 7 November 2024 : Oxford

In total, 48 clinicians attended the OReCO Oxford workshop from 4 hospitals across the Oxfordshire region.

  • Broad range of topics – particularly useful to hear about rationale for neoadjuvant treatment decisions.
  • It allowed me to recognise that lymph nodes in isolation are not as prognostically important as once thought.
  • Lots of useful tips. Highlighting importance of patient choice e.g. with operation choice, risk of LARS etc.

Scotland Chapter : 11 September 2024 : Edinburgh

In total, 62 healthcare professionals attended the OReCO Scotland workshop from 17 hospitals across the region.

  • It has been good for team building in our MDT and we are thinking of returning to face-to-face MDT meetings rather than using teams.
  • Motivates us to continue to develop our current service to benefit the patients. Widened knowledge particularly on oncological aspects of treatment of rectal cancer.
  • As a pathologist, better understanding of the implications of my reports and importance of MDT discussions.

 

North Wales Chapter : 19 July 2024 : Conwy

In total, 41 clinicians attended the OReCO North Wales workshop from 3 hospitals across the region.

  • The importance of different clinical options relating to treatment options and the need to discuss these with patients. Good discussions after each presentation
  • As a colorectal nurse I can definitely use the LARS templates and Q&A.
  • Provided me with more insight into rectal cancer treatments, complications & risks of surgery & the impact on patient’s quality of life

London Chapter : 2 May 2024 : London

In total, there were 146 attendees at the OReCO London workshop from 26 hospitals across the region.

  • It will greatly impact our views in discussing rectal cancers in MDT and to patients.
  • We need the things that have been discussed in this meeting formalised and distributed. This information is imperative to the good functioning of our MDT’s.
  • Feel better informed about making decisions, although areas of uncertainty remain for all, I feel better informed of known unknowns.

 

South Wales Chapter : 11 March 2024 : Newport

In total, there were 53 attendees at the OReCO London workshop from 9 hospitals across the region.

  • Greater understanding of all the issues that need consideration. Better appreciation for issues important to other specialists in MDT
  • Discussion around the cases were really interesting and useful
  • Functional bowel – post TME most valuable as this is the biggest factor that has the most patient impact post-surgery

 

 

Wessex Chapter : 24th January 2024 : Basingstoke

In total, there were 48 attendees at the OReCO London workshop from 7 hospitals across the region.

  • Really valuable to discuss difficult cases and see the variation in opinion. Good to meet with local colleagues as we don’t do this enough.
  • Expert discussion of the problems we see routinely and don’t have answers to.
  • All very informative. Enjoyed the MDT and interactive discussions.

 

 

 

If you would like to hear more about Pelican OReCO and how you can support this programme please contact Jane Staff: j.staff@pelicancancer.org

Stay in touch

Sign up to hear from us
Donate Now

© 2023 Pelican Cancer Foundation - all rights reserved

  Registered Charity Number: 1141911 -  Privacy Policy